EXAGEN INC. Accrued Liabilities, Current
EXAGEN INC. (XGN) had Accrued Liabilities, Current of $4.94 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Accrued Liabilities, Current $4.94M.
- 2026-03-31: Accrued Liabilities, Current $4.77M.
- 2025-12-31: Accrued Liabilities, Current $6.33M.
- 2025-09-30: Accrued Liabilities, Current $5.68M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.94M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $4.77M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $6.33M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $5.68M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $4.94M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $4.95M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $6.92M 10-K · filed 2026-03-10 | $7.85M 10-K · filed 2025-03-11 |
| 2024-09-30 | $6.18M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $5.66M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $6.04M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $7.53M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $7.06M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.93M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $6.06M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.35M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $6.65M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $5.97M 10-Q/A · filed 2022-11-21 | $5.49M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.72M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $6.83M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $6.58M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.82M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $5.71M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $5.76M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $5.82M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $4.32M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $4.76M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.42M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $6.45M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $3.92M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |